Cancer Care and Hematology Specialists of Chicagoland

Winfield, Illinois 60190

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer

Studies at this site

• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early